miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
about
MicroRNA in carcinogenesis & cancer diagnostics: a new paradigmMicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and developmentMechanism of T cell regulation by microRNAsMicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemiaExpression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenograftsClinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphomaTransgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytesΔ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells.MicroRNAs and STAT interplay.Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma.microRNA-20a Inhibits Autophagic Process by Targeting ATG7 and ATG16L1 and Favors Mycobacterial Survival in Macrophage Cells.A Prediction Model Based on Biomarkers and Clinical Characteristics for Detection of Lung Cancer in Pulmonary Nodules.High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.Targeting the tumor microenvironment by immunotherapy: part 2.Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme.MicroRNA control in the development of systemic autoimmunity.MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.Noncoding RNAs in Cancer Immunology.MicroRNA 17-92 expressed by a transposone-based vector changes expression level of cell-cycle-related genes.Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders.Increased expression of microRNA-17 predicts poor prognosis in human glioma.miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice.Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.microRNA cluster 106a~363 is involved in T helper 17 cell differentiation.A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer.
P2860
Q26863669-52678473-EC10-4911-BE42-8CCB2689BEF8Q27003271-CEF888E8-8F66-488E-947F-C06F0ED84D36Q27026265-8C7377C0-32B4-44DD-BA6E-6C9438CC1F17Q28260580-637A2ED4-945C-4C14-BD7E-14404AB04F66Q33606096-B4CB01D1-08DF-4D6C-B594-76252125D0B0Q33839512-5419C900-1A48-4558-AC3B-6F22340E59CBQ35163556-C2C1B5ED-95A0-4C64-B009-AAFA73E1F5DEQ35175779-3245BC5F-81DE-4B60-8555-3C6EC4073B0CQ35223945-EB7F866E-39C5-407F-B474-7A2EAA94A21EQ35785559-6CBD9B26-F259-49DC-A6EF-2B949EEC13E5Q36101421-9738A8C8-4DBE-43AB-B356-6B643E4689AAQ36716083-E422DDDA-2EEB-4293-B480-290D83128BA0Q37345091-3C9F3B55-59E2-4E2C-8785-E31C3B8E5BDAQ37447387-7AFD8659-4FA5-417D-9DE3-CB4DD61A85F8Q37451898-69922F80-5A75-4D9D-AF7D-DB73B355DE0AQ37952796-C0C7CE6B-48A5-46C6-BCD6-4E76484FCB5EQ38034755-7F624747-CE4D-4B35-937B-9EA086A69353Q38078996-308B27C4-389C-497E-BF54-AE45062B6056Q38098095-872DBD25-7EC5-44D8-BB6F-63FE96088AC7Q38418114-45773C56-6626-4AD4-8595-279543387236Q38885490-F7B059CA-7A1E-42C2-8FB6-C0724CA2D618Q39325636-F52CF20E-FE2E-4025-9192-9D1E62ADC61AQ40787161-15459552-C793-45AF-8E15-C3674C5EC305Q41808943-28254EC6-47DD-4779-B51B-5065AFC9D382Q42563520-62A0F8F7-49E9-46DB-B874-62C2FDA16231Q43571883-E121C831-F1A3-4D8C-B776-FD7367932854Q48096559-C7BC2812-5300-43D3-B0C1-39349ADF4053Q48272678-BB1C6DF1-B1BA-430B-AFA4-725F5B17CD3EQ50225594-2E14652E-3C24-4434-BAD8-E65E4BFABBB2Q50321693-99B330E1-F8B7-43EF-8B62-6316D3777BB4
P2860
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@ast
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en-gb
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@nl
type
label
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@ast
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en-gb
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@nl
prefLabel
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@ast
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en-gb
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@nl
P2093
P2860
P50
P3181
P356
P1476
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy
@en
P2093
Francesco M Marincola
Heather A McDonald
Hideho Okada
Kotaro Sasaki
Michael T Lotze
Todd A Reinhart
P2860
P2888
P3181
P356
10.1186/1479-5876-8-17
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1007088630